Announcements Trials
Browse Landscape

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

CNS 1

Conditions

Keratosis, Actinic 3Glioma 3Glioblastoma 2Carcinoma, Basal Cell 2Brain Neoplasms 2Skin Neoplasms 1Pituitary Neoplasms 1Oligodendroglioma 1Neuroectodermal Tumors 1Neoplasms, Neuroepithelial 1Neoplasms, Basal Cell 1Neoplasms 1Neoplasm, Residual 1Neoplasm Metastasis 1Central Nervous System Neoplasms 1Carcinoma, Squamous Cell 1Astrocytoma 1

Interventions

Radiotherapy 19Temozolomide 11Cisplatin 9Vincristine 8Chemotherapy, Adjuvant 8Carboplatin 8Etoposide 6Lomustine 5Methotrexate 4Thiotepa 3Peripheral Blood Stem Cell Transplantation 3Magnetic Resonance Spectroscopy 3Ifosfamide 3Filgrastim 3Cyclophosphamide 3Carmustine 3pegfilgrastim 2Tamoxifen 2Surgical Procedures, Operative 2Psychiatric Rehabilitation 2Pemetrexed 2Mental Status and Dementia Tests 2Hyperbaric Oxygenation 2Ethanol 2Erlotinib Hydrochloride 2Dexamethasone 2Amplified Fragment Length Polymorphism Analysis 2nedaplatin 1motexafin gadolinium 1lonafarnib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Central Nervous System Neoplasms × Aminolevulinic Acid × Clear all
NCT05850377 2023-05-09

5-Aminolevulinic Acid (5-ALA) Gliolan®: Usage Increase Proposal for Neurosurgical Procedures in High-Grade Gliomas

Sociedad de Lucha Contra el Cáncer del Ecuador

Unknown
90 enrolled
CNS

Brain Neoplasms, Glioma, Neoplasms, Central Nervous System Neoplasms, Neuroectodermal Tumors, Neoplasms, Neuroepithelial, Neoplasm, Residual

Data powered by HemOnc (CC BY 4.0) Colophon âš¡